Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
Adithya CattamanchiTania F RezaTalemwa NalugwaKatherine AdamsMariam NantaleDenis OyukuSarah NabwireDiana BabiryeStavia TuryahabweAustin TuckerHojoon SohnOlivia FergusonRyan R ThompsonPriya B SheteMargaret A HandleySara AckermanMoses JolobaDavid A J MooreJ Lucian DavisDavid W DowdyKatherine FieldingAchilles KatambaPublished in: The New England journal of medicine (2022)
A multicomponent diagnostic strategy that included on-site molecular testing plus implementation supports to address barriers to delivery of high-quality tuberculosis evaluation services led to greater numbers of patients being tested, receiving a diagnosis, and being treated for confirmed tuberculosis. (Funded by the National Heart, Lung, and Blood Institute; XPEL-TB ClinicalTrials.gov number, NCT03044158.).
Keyphrases
- mycobacterium tuberculosis
- end stage renal disease
- primary care
- pulmonary tuberculosis
- healthcare
- newly diagnosed
- hiv aids
- ejection fraction
- chronic kidney disease
- heart failure
- peritoneal dialysis
- mental health
- prognostic factors
- adverse drug
- single molecule
- atrial fibrillation
- patient reported outcomes
- human immunodeficiency virus